{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:13:50Z","timestamp":1791843230659,"version":"4.3.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00302","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T05:14:46Z","timestamp":1557810886000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ART"],"prefix":"10.3389","volume":"10","author":[{"given":"Elisa","family":"Dalla Grana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Lanzafame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Lattuada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Suardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mottes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Dalle Carbonare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS."},{"key":"B2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis."},{"key":"B3","first-page":"39","article-title":"Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy","volume":"48","author":"Madeddu","year":"2004","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/00002030-200109070-00019","article-title":"Reduced bone mineral density in HIV-positive individuals","volume":"15","author":"Moore","year":"2001","journal-title":"AIDS."},{"key":"B5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","article-title":"Reduced bone mineral density in HIV-infected patients: prevalence and associated factors","volume":"22","author":"Cazanave","year":"2008","journal-title":"AIDS."},{"key":"B6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11908-006-0025-5","article-title":"Metabolic abnormalities in HIV-infected patients: an update","volume":"8","author":"Brown","year":"2006","journal-title":"Curr Infect Dis Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00223-018-0474-5","article-title":"Vitamin D and bone mineral density in HIV newly diagnosed therapy-naive patients without any secondary causes of osteoporosis","volume":"104","author":"Ceballos","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11904-014-0216-x","article-title":"Bone alterations associated with HIV.","volume":"11","author":"Warriner","year":"2014","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/MED.0000000000000200","article-title":"Bone loss in HIV: a contemporary review","volume":"22","author":"Hileman","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S2213-8587(13)70181-5","article-title":"Skeletal health in adults with HIV infection","volume":"3","author":"Bolland","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/bonekey.2015.3","article-title":"HIV infection and osteoporosis","volume":"4","author":"Compston","year":"2015","journal-title":"Bonekey Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/QAD.0b013e3283292195","article-title":"Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults","volume":"23","author":"Collin","year":"2009","journal-title":"AIDS."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00198-007-0428-7","article-title":"Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study","volume":"18","author":"Prior","year":"2007","journal-title":"Osteoporos Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1097\/QAD.0b013e32833f6294","article-title":"Fracture incidence in HIV-infected women: results from the women's interagency HIV study","volume":"24","author":"Yin","year":"2010","journal-title":"AIDS."},{"key":"B16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/COH.0000000000000249","article-title":"Do people with HIV infection have a higher risk of fracture compared with those without HIV infection?","volume":"11","author":"Hoy","year":"2016","journal-title":"Curr Opin HIV AIDS."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e17217","DOI":"10.1371\/journal.pone.0017217","article-title":"Increased risk of fragility fractures among HIV infected compared to uninfected male veterans","volume":"6","author":"Womack","year":"2011","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/cid\/ciq242","article-title":"Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006","volume":"52","author":"Young","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1097\/QAD.0000000000000363","article-title":"Osteoporosis and fractures in HIV\/hepatitis C virus coinfection: a systematic review and meta-analysis","volume":"28","author":"Dong","year":"2014","journal-title":"AIDS."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/jbmr.1988","article-title":"Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients","volume":"28","author":"Maalouf","year":"2013","journal-title":"J Bone Miner Res."},{"key":"B21","first-page":"25","article-title":"Prevalence of sub-clinical vertebral fractures in HIV-infected patients","volume":"37","author":"Borderi","year":"2014","journal-title":"New Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12020-011-9586-7","article-title":"High prevalence of radiological vertebral fractures in HIV-infected males","volume":"41","author":"Torti","year":"2012","journal-title":"Endocrine."},{"key":"B23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11657-018-0464-2","article-title":"Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age","volume":"13","author":"Llop","year":"2018","journal-title":"Arch Osteoporos."},{"key":"B24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00774-017-0819-6","article-title":"Trabecular bone score (TBS) is associated with sub-clinical vertebral fractures in HIV-infected patients","volume":"36","author":"Ciullini","year":"2018","journal-title":"J Bone Miner Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2013a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1210\/jc.2008-0791","article-title":"Prevalence of vertebral fractures in men with acromegaly","volume":"93","author":"Mazziotti","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/QAD.0b013e32835192ae","article-title":"Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents","volume":"26","author":"Bedimo","year":"2012","journal-title":"AIDS."},{"key":"B28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/QAD.0b013e32834ed8a7","article-title":"Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study","volume":"26","author":"Hansen","year":"2012","journal-title":"AIDS."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/QAD.0b013e328351997f","article-title":"Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case-control analysis in a health-insured population","volume":"26","author":"Mundy","year":"2012","journal-title":"AIDS."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jocd.2011.06.004","article-title":"Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population","volume":"14","author":"Pinto Neto","year":"2011","journal-title":"J Clin Densitom."},{"key":"B32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/1471-2334-12-192","article-title":"Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects","volume":"12","author":"Li Vecchi","year":"2012","journal-title":"BMC Infect Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/infdis\/jiv194","article-title":"Changes in bone mineral density after initiation of antiretroviral treatment with Tenofovir Disoproxil Fumarate\/Emtricitabine Plus Atazanavir\/Ritonavir, Darunavir\/Ritonavir, or Raltegravir","volume":"212","author":"Brown","year":"2015","journal-title":"J Infect Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1471-2474-14-224","article-title":"Bone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study","volume":"14","author":"Zhang","year":"2013","journal-title":"BMC Musculoskelet Disord."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1097\/QAD.0b013e328361d241","article-title":"Incident fractures in HIVinfected individuals: a systematic review and meta-analysis","volume":"27","author":"Shiau","year":"2013","journal-title":"AIDS."},{"key":"B36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.clnu.2013.04.018","article-title":"Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients","volume":"33","author":"Theodorou","year":"2014","journal-title":"Clin Nutr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3851\/IMP1502","article-title":"Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.","volume":"15","author":"Brown","year":"2010","journal-title":"Antivir Ther (Lond)."},{"key":"B38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3851\/IMP2721","article-title":"Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)","volume":"19","author":"Wohl","year":"2014","journal-title":"Antivir Ther (Lond)."},{"key":"B39","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.3390\/ijms19010119","article-title":"Vitamin D status and the relationship with bone fragility fractures in HIV-infected patients: a case control study","volume":"19","author":"Atteritano","year":"","journal-title":"Int J Mol Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/1471-2334-13-577","article-title":"Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients","volume":"13","author":"Piso","year":"2013","journal-title":"BMC Infect Dis."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00302\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T05:14:50Z","timestamp":1557810890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00302\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":40,"alternative-id":["10.3389\/fendo.2019.00302"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00302","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"article-number":"302"}}